Evidence map›Paper›PMID 39774613›Full record

ArticleScientific reports2025

Examination of the requirements for powered air-purifying respirator (PAPR) utilization as an alternative to lockdown.

Yusaku Fujii

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yusaku FujiiGunma University, 1-5-1 Tenjin-Cho, Kiryu, 376-8515, Japan. fujii@gunma-u.ac.jp.

Funding

Japan Society for the Promotion of Science 21KK0080
6 · The paper itself

Abstract

With the emergence of COVID-19 variants and new viruses, it remains uncertain when the next pandemic will occur. A lockdown is considered the last resort to halt the spread of infection; however, it causes significant economic and social damage. Therefore, exploring less harmful alternatives during such scenarios is crucial. This study explores the feasibility of using a powered air-purifying respirator (PAPR) as an alternative to lockdowns and as a strategy for infection control. Specifically, the study examines the potential impact of the PAPR wearing rate and PAPR aerosol shielding performance on the controllability of the spread of infections. The study investigated the necessary PAPR wearing rate and aerosol shielding performance to control infections as an alternative to the lockdown, using a simple simulation under limited conditions. When using a PAPR with 100% aerosol shielding capability in air supply, only 55% of the population needs to consistently wear the PAPR to reduce the effective reproduction number from a critical level (R

Indexed as

COVID-19Respiratory Protective DevicesSARS-CoV-2AerosolsHumansPandemicsAerosolsAirborne transmissionCOVID-19Emergency evacuationHerd immunityInfectious doseLockdownPowered Air-Purifying Respirator (PAPR)

Identifiers

PMID39774613
PMCPMC11707360

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.